Tricuspid regurgitation thresholds reassessed

• by Kathryn Wighton

• September 9, 2026

Influence of left ventricular ejection fraction on the clinical outcome of percutaneous coronary interventions in heart transplant patients

• by Luisa Elbinger, Tobias Schupp, Michael Behnes, Ibrahim Akin, Angelika Costard-Jäckle, Rene Schramm, Tanja Rudolph, Volker Rudolph, Mohamed Ayoub

• October 7, 2026

FDA updates PAH label with trial data

In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.

• by Kathryn Wighton

• September 22, 2026

• 3 min

Disparities in the management of cardiogenic shock complicating acute myocardial infarction: a questionnaire survey in Beijing

• by Yidan Ren, Yuwei Liu, Yaxin Xie, Chenxu Zhao, Xiaqiu Tian, Liangshan Wang, Zhongtao Du, Xing Hao, Chenglong Li, Xiaotong Hou, Hong Wang

• September 25, 2026